With a physician mother and geologist father, Katie Morris, Ph.D., was immersed in the world of science from a young age. | ...
As Merck looks for growth opportunities ahead of Keytruda’s tumble over the patent cliff, the company’s future now looks a ...
The FDA has issued another complete response letter (CRL) to Regeneron, rejecting its bid for approval of its prefilled syringe version of high-dose (HD) Eylea—again for unresolved issues at the ...
Shortly after taking reins at BioMarin, CEO Alexander Hardy laid out three paths the company could take for its struggling ...
Novartis has started to feel the squeeze from generics to its top-selling drug, heart therapy Entresto. | Novartis has ...
The FDA has slammed generic drug maker Hetero Labs with a Form 483 after an inspection of one of its warehouses in India ...
Citing insurance claims data, CSL’s leaders said they expect this season's flu vaccination rates in the U.S. to decline by 12% overall and by 14% for people ages 65 and older compared with last year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback